Avalo Therapeutics, Inc. Quarterly Goodwill in USD from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Avalo Therapeutics, Inc. quarterly Goodwill history and growth rate from Q4 2016 to Q3 2024.
  • Avalo Therapeutics, Inc. Goodwill for the quarter ending September 30, 2024 was $10.5M, a 27.1% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $10.5M -$3.91M -27.1% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $10.5M -$3.91M -27.1% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $10.5M -$3.91M -27.1% Mar 31, 2024 10-Q/A 2024-07-11
Q4 2023 $10.5M -$3.91M -27.1% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $14.4M $0 0% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $14.4M $0 0% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $14.4M $0 0% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $14.4M $0 0% Dec 31, 2022 10-K 2024-03-29
Q3 2022 $14.4M $0 0% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $14.4M $0 0% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $14.4M $0 0% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $14.4M $0 0% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $14.4M -$88 0% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $14.4M -$88 0% Jun 30, 2021 10-Q 2021-08-02
Q1 2021 $14.4M -$88 0% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $14.4M -$88 0% Dec 31, 2020 10-K 2022-03-02
Q3 2020 $14.4M -$2M -12.2% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $14.4M -$2M -12.2% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $14.4M -$2M -12.2% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $14.4M $0 0% Dec 31, 2019 10-K 2021-03-08
Q3 2019 $16.4M $0 0% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $16.4M -$1.66M -9.18% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $16.4M -$2.27M -12.1% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $14.4M +$2.12M +17.2% Dec 31, 2018 10-K 2020-03-11
Q3 2018 $16.4M Sep 30, 2018 10-Q 2018-11-13
Q2 2018 $18.1M Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $18.7M Mar 31, 2018 10-Q 2018-05-11
Q4 2017 $12.3M +$12.3M Dec 31, 2017 10-K 2020-03-11
Q4 2016 $0 Dec 31, 2016 10-K 2019-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.